Analgesics, Antipyretics & NSAIDs

The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.

21 products Paracetamol · ibuprofen · aspirin · diclofenac · piroxicam · mefenamic acid · naproxen · indomethacin
5 sourced statements Reference: WHO Model List of Essential Medicines, 24th List (September 2025) Reviewed 2026-10-05

Paracetamol, ibuprofen and acetylsalicylic acid are the three non-opioid analgesics named in section 2.1 of the WHO Model List. All three are antipyretic and analgesic; paracetamol is explicitly not recommended for anti-inflammatory use, because the benefit is not proven.

At a glance

  • All three Model List non-opioid analgesics — paracetamol, ibuprofen, aspirin — are in our range.
  • Paracetamol is listed as an antipyretic and analgesic, not an anti-inflammatory.
  • WHO warns against offering both 120 mg/5 mL and 125 mg/5 mL paracetamol liquids on one market.
  • Ibuprofen is not indicated below three months of age per the Model List.
  • We supply 21 analgesic products across six dosage forms, including paediatric weight-band presentations.

01What the published guidance says

Every statement below is drawn from WHO or MSF published material and linked to its source. We summarise; we do not reproduce. Statements marked as our own are commercial positions, not clinical guidance.

The Model List specifies the exact presentations

Section 2.1 of the 24th WHO Model List (2025) lists acetylsalicylic acid (suppository 50–150 mg; tablet 100–500 mg), ibuprofen (oral liquid 100 mg/5 mL; tablet 200, 400 and 600 mg) and paracetamol (oral liquid 120 mg/5 mL or 125 mg/5 mL and 250 mg/5 mL; suppository 100 and 250 mg; tablet 250, 325 and 500 mg; dispersible tablet 100 and 250 mg).

A strength-confusion warning that matters commercially

The Model List itself warns that the presence of both 120 mg/5 mL and 125 mg/5 mL paracetamol oral liquid strengths on the same market would cause confusion in prescribing and dispensing and should be avoided. Country programmes should therefore settle on one strength.

Paracetamol is an antipyretic and analgesic — not an anti-inflammatory

The Model List carries a footnote stating paracetamol is not recommended for anti-inflammatory use due to lack of proven benefit to that effect. Marketing copy that positions paracetamol as an anti-inflammatory is inconsistent with the WHO listing.

Age limits worth building into your labelling

Ibuprofen is not indicated in children less than three months of age according to the Model List. Paediatric paracetamol dosing should follow national formulary weight bands.

Fever control is part of severe-disease management

MSF guidance on severe malaria directs paracetamol in the event of high fever only — a reminder that in febrile illness the antipyretic is supportive care, not the disease treatment.

02Products in this therapeutic group

Each entry links to its full specification page.

Products supplied by Sinophare Bio-technology Co., Ltd. in the Analgesics & NSAIDs therapeutic area
Product Dosage form Presentation notes Detail
Paracetamol syrup 500mg/15ml total 100ml Syrup   View Paracetamol syrup 500mg/15ml total 100ml →
Paracetamol oral solution containing 1000mg Syrup   View Paracetamol oral solution containing 1000mg →
Paracetamol oral solution 325mg per 10ml Syrup   View Paracetamol oral solution 325mg per 10ml →
Paracetamol Oral Suspension 160mg per 5mL Suspension   View Paracetamol Oral Suspension 160mg per 5mL →
Ibuprofen Oral Suspension 100mg/5mL Suspension Pediatric Fever & Pain View Ibuprofen Oral Suspension 100mg/5mL →
Paracetamol Injection 500mg/5mL Injection IV Analgesic Antipyretic View Paracetamol Injection 500mg/5mL →
Diclofenac Sodium Injection 3ml:75mg Injection   View Diclofenac Sodium Injection 3ml:75mg →
Lysine Acetylsalicylate Injection 900mg Injection   View Lysine Acetylsalicylate Injection 900mg →
Piroxicam Injection 10mg/ml Injection   View Piroxicam Injection 10mg/ml →
Paracetamol 500mg Effervescent Tablets Tablet   View Paracetamol 500mg Effervescent Tablets →
Paracetamol 500mg Tablets Tablet   View Paracetamol 500mg Tablets →
Methamizole 500mg Tablets Tablet   View Methamizole 500mg Tablets →
Ibuprofen 100mg Tablets Tablet   View Ibuprofen 100mg Tablets →
Copara compound tablets with Paracetamol 500mg Tablet   View Copara compound tablets with Paracetamol 500mg →
Aspirin Tablets 300mg Tablet   View Aspirin Tablets 300mg →
Mefenamic Capsules 250mg Capsule   View Mefenamic Capsules 250mg →
Diclofenac Sodium 50mg Capsules Capsule   View Diclofenac Sodium 50mg Capsules →
Paracetamol Suppository 150mg Suppository Rectal Analgesic & Antipyretic for Fever View Paracetamol Suppository 150mg →
Naproxen Suppositories 250mg Suppository   View Naproxen Suppositories 250mg →
Indomethacin Suppository 100mg Suppository NSAID for Severe Pain, Fever & Inflammation View Indomethacin Suppository 100mg →
Ibuprofen Suppository 50mg Suppository Pediatric NSAID for Fever & Mild Pain Relief View Ibuprofen Suppository 50mg →

21 products in this group · part of 186 finished dosage forms across 14 therapeutic areas.

03Specifying your order

The five things worth stating on a purchase order for this group, so the quotation comes back right first time.

Single liquid strength

Tell us which paracetamol oral-liquid strength your formulary has adopted. We will supply one strength only, avoiding the mix-up the Model List warns about.

Dosage form

Tablet, dispersible, effervescent, capsule, oral suspension, syrup, suppository or injection — each has a different lead time and pack format.

Paediatric presentation

State the weight band and whether you need a graduated dosing device packaged with the bottle.

Effervescent composition

Specify the sodium content and any sugar or sugar-alcohol requirement, since these matter in some patient groups.

Suppository strength

Confirm the strength, as the Model List specifies 100 mg and 250 mg while national formularies often add intermediates.

04How we supply it

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Every route

Tablets, dispersible and effervescent tablets, capsules, oral suspensions and syrups, suppositories, and injectable paracetamol, diclofenac, piroxicam and lysine acetylsalicylate.

Paediatric focus

Weight-band oral suspensions and low-strength suppositories, including the paediatric ibuprofen and paracetamol presentations used in fever protocols.

Single-strength discipline

We will supply one paracetamol oral-liquid strength per market on request, to avoid the confusion the Model List warns about.

Documentation

COA with assay, dissolution and related substances; stability data; dossier and registration support.

05Safety, labelling & regulatory notes

Points worth carrying into your tender, label review or clinical briefing.

  • Confirm which paracetamol oral-liquid strength your national formulary has adopted and specify a single strength on the purchase order.
  • Avoid positioning paracetamol as an anti-inflammatory in promotional material.
  • Diclofenac is not listed on the WHO Model List — stock it only where your national essential medicines list includes it.
  • Aspirin in febrile children carries a Reye's syndrome risk in many national labels. Confirm the local prescribing information restricts paediatric use accordingly.

06Questions buyers ask

6 answers covering specification, documentation and regulatory questions for this group.

Which strengths of paracetamol oral liquid should we order?
The WHO Model List notes that offering both 120 mg/5 mL and 125 mg/5 mL on one market causes prescribing and dispensing confusion. We recommend selecting one strength per market and will supply accordingly.
Do you supply paracetamol suppositories?
Yes — 150 mg and paediatric strengths. The Model List specifies suppository strengths of 100 mg and 250 mg, and national formularies frequently add intermediates.
Is diclofenac on the WHO Essential Medicines List?
No. The non-opioid analgesics named in section 2.1 are acetylsalicylic acid, ibuprofen and paracetamol. We supply diclofenac sodium in injectable and capsule form for markets whose national lists include it.
Can you supply sustained-release or combination analgesics?
Yes — including compound presentations and sustained-release forms. Confirm the specific combination against your national registration before ordering.
Do you supply paediatric paracetamol in weight-band dosing?
Yes. We supply oral suspensions, syrups and low-strength suppositories in weight-band presentations, together with a graduated dosing device where required.
Can you supply paracetamol injection?
Yes — paracetamol 500 mg/5 mL injection is part of the range, supplied with sterility and bacterial endotoxin results on the batch COA.

07Related therapeutic areas

Adjacent groups you may want to combine on one purchase order.

Request a quotation for Analgesics & NSAIDs

Send us the products, strengths and pack sizes you need, together with the destination country, and we will return a quotation with the documentation package and lead time. Registration support documents are provided with every order.

Request a quotation →
Or write to info@sinophare.com